Article Text
PostScript
Letter
Understanding clinically significant risks in intravenous ketamine therapy
Statistics from Altmetric.com
You do not have access to the full text of this article, the first page of the PDF of this article appears above.
Footnotes
Contributors TM and BA conceptualized and wrote the letter. MH reviewed and revised the manuscript. All authors read and approved the submission of the letter in its current form.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
Linked Articles
- PostScript